Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathways.

Molecular biology reports·2026
Same author

Preoperative Quality of Life as Predictor of Postoperative Early Recurrence and Overall Survival in Patients with Pancreatic and Periampullary Adenocarcinoma.

Journal of gastrointestinal cancer·2026
Same author

Prognostic value of Combined Progression Index (CPI) in 132 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy.

Human pathology·2026
Same author

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Safety of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients.

Clinical physiology and functional imaging·2026
Same author

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Lancet (London, England)·2026

Related Experiment Video

Updated: Mar 12, 2026

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
07:31

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

6.2K

Danish Pancreatic Cancer Database.

Claus Fristrup1, Sönke Detlefsen2, Carsten Palnæs Hansen3

  • 1Department of Surgical Gastroenterology.

Clinical Epidemiology
|November 9, 2016
PubMed
Summary

The Danish Pancreatic Cancer Database prospectively collected data on 2,217 patients with pancreatic cancer. The 3-year survival rate was 6%, highlighting the need for improved pancreatic cancer outcomes.

Keywords:
national databasepancreatic cancersurvival

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Published on: May 12, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 12, 2026

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
07:31

Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

6.2K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Published on: May 12, 2023

1.8K

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Pancreatic cancer presents a significant public health challenge with poor survival rates.
  • Establishing comprehensive national registries is crucial for understanding disease epidemiology and improving patient outcomes.

Approach:

  • The Danish Pancreatic Cancer Database prospectively collected data from May 2011 to June 2014.
  • Data included demographics, diagnosis, treatment, and outcomes for 2,217 patients with ductal adenocarcinoma.
  • Cross-referencing with national registries ensured data completeness (82%) and accurate survival monitoring.

Key Points:

  • Detailed clinical data, including tumor stage and treatment modalities, were systematically recorded.
  • Treatment variables encompassed surgical procedures, chemotherapy, and chemoradiation, providing insights into management strategies.
  • Patient survival was monitored via the Danish Civil Registry, ensuring comprehensive outcome assessment.

Conclusions:

  • The database provides a valuable resource for analyzing pancreatic cancer trends in Denmark.
  • The observed 3-year survival rate of 6% underscores the aggressive nature of pancreatic cancer and the need for enhanced therapeutic strategies.